Technical Analysis for MYOV - Myovant Sciences Ltd.
|Grade||Last Price||% Change||Price Change|
MYOV closed up 2.3 percent on Wednesday, January 16, 2019, on 1.3 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Down||Up||Up|
|See historical MYOV trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||Crossed Above 50 DMA||Bullish||0.00%|
|Jan 16||MACD Bullish Centerline Cross||Bullish||0.00%|
|Jan 16||Pocket Pivot||Bullish Swing Setup||0.00%|
|Jan 16||Stochastic Reached Overbought||Strength||0.00%|
|Jan 16||Overbought Stochastic||Strength||0.00%|
|Jan 16||Upper Bollinger Band Touch||Strength||0.00%|
|Jan 15||50 DMA Resistance||Bearish||2.30%|
|Jan 14||Down 3 Days in a Row||Weakness||7.74%|
|Jan 11||Narrow Range Bar||Range Contraction||4.89%|
|Jan 11||NR7||Range Contraction||4.89%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more MYOV news...
|52 Week High||27.45|
|52 Week Low||12.76|
|200-Day Moving Average||21.1926|
|50-Day Moving Average||18.347|
|20-Day Moving Average||16.9475|
|10-Day Moving Average||17.654|
|Average True Range||1.0631|
|Chandelier Exit (Long, 3 ATRs )||15.8007|
|Chandelier Exit (Short, 3 ATRs )||17.5093|
|Upper Bollinger Band||18.8329|
|Lower Bollinger Band||15.0621|
|Percent B (%b)||0.95|
|MACD Signal Line||-0.2973|
|Market Cap||1.14 Billion|
|Num Shares||60.8 Million|
|Price-to-Earnings (P/E) Ratio||-11.45|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||20.35|
|Resistance 3 (R3)||20.25||19.59||20.07|
|Resistance 2 (R2)||19.59||19.16||19.64||19.97|
|Resistance 1 (R1)||19.13||18.89||19.36||19.22||19.88|
|Support 1 (S1)||18.00||18.04||18.23||18.10||17.44|
|Support 2 (S2)||17.34||17.77||17.39||17.35|
|Support 3 (S3)||16.88||17.34||17.25|
|Support 4 (S4)||16.97|